• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-26a通过直接靶向结肠癌细胞中的丙酮酸脱氢酶复合物E1α亚基来调节葡萄糖代谢。

MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells.

作者信息

Chen Bing, Liu Yuling, Jin Xuewen, Lu Weiliang, Liu Jingjing, Xia Zijing, Yuan Qiong, Zhao Xia, Xu Ningzhi, Liang Shufang

机构信息

State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, No,17, the third section of Renmin South Road, Chengdu 610041, P, R, China.

出版信息

BMC Cancer. 2014 Jun 16;14:443. doi: 10.1186/1471-2407-14-443.

DOI:10.1186/1471-2407-14-443
PMID:24935220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4071217/
Abstract

BACKGROUND

Reprogramming energy metabolism has been an emerging hallmark of cancer cells. MicroRNAs play important roles in glucose metabolism.

METHODS

The targets of microRNA-26a (miR-26a) were predicted by bioinformatics tools. The efficacy of miR-26a binding the 3'-untranslated region (UTR) of pyruvate dehydrogenase protein X component (PDHX) mRNA was evaluated using a dual-luciferase reporter assay. The PDHX expression at the mRNA and protein level in several colon cancer cell lines was quantified with real-time PCR and Western blot analysis respectively. The effects of miR-26a on glucose metabolism were determined by detecting the content of glucose consumption, production of lactate, pyruvate, and acetyl-coenzyme A.

RESULTS

The expression of miR-26a is inversely associated with the level of its targeting protein PDHX in several colon cancer cell lines with different malignancy potentials. MiR-26a inhibits PDHX expression by direct targeting the 3'-UTR of PDHX mRNA. The glucose consumption and lactate concentration were both greatly increased in colon cancer cells than the normal colon mucosal epithelia under physiological conditions. The overexpression of miR-26a in HCT116 cells efficiently improved the accumulation of pyruvate and decreased the production of acetyl coenzyme A. Meanwhile the inhibition of miR-26a expression induced inverse biological effects.

CONCLUSIONS

MiR-26a regulates glucose metabolism of colorectal cancer cells by direct targeting the PDHX, which inhibits the conversion of pyruvate to acetyl coenzyme A in the citric acid cycle.

摘要

背景

能量代谢重编程一直是癌细胞新出现的一个特征。微小RNA在葡萄糖代谢中发挥重要作用。

方法

通过生物信息学工具预测微小RNA-26a(miR-26a)的靶标。使用双荧光素酶报告基因检测法评估miR-26a与丙酮酸脱氢酶蛋白X组分(PDHX)mRNA的3'-非翻译区(UTR)结合的效力。分别通过实时PCR和蛋白质印迹分析对几种结肠癌细胞系中PDHX在mRNA和蛋白质水平的表达进行定量。通过检测葡萄糖消耗、乳酸、丙酮酸和乙酰辅酶A的生成量来确定miR-26a对葡萄糖代谢的影响。

结果

在几种具有不同恶性潜能的结肠癌细胞系中,miR-26a的表达与其靶向蛋白PDHX的水平呈负相关。miR-26a通过直接靶向PDHX mRNA的3'-UTR抑制PDHX表达。在生理条件下,结肠癌细胞中的葡萄糖消耗和乳酸浓度均比正常结肠黏膜上皮细胞大幅增加。HCT116细胞中miR-26a的过表达有效促进了丙酮酸的积累并降低了乙酰辅酶A的生成。同时,抑制miR-26a的表达诱导了相反的生物学效应。

结论

miR-26a通过直接靶向PDHX调节结肠癌细胞的葡萄糖代谢,这抑制了柠檬酸循环中丙酮酸向乙酰辅酶A的转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/465ed521adb4/1471-2407-14-443-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/d0abf44ec3b7/1471-2407-14-443-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/78eaeefb6c94/1471-2407-14-443-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/f2990590dedc/1471-2407-14-443-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/46ddfe47d8d4/1471-2407-14-443-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/beb18e4adfc4/1471-2407-14-443-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/3dca80261674/1471-2407-14-443-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/c0145ecfc6f9/1471-2407-14-443-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/465ed521adb4/1471-2407-14-443-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/d0abf44ec3b7/1471-2407-14-443-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/78eaeefb6c94/1471-2407-14-443-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/f2990590dedc/1471-2407-14-443-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/46ddfe47d8d4/1471-2407-14-443-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/beb18e4adfc4/1471-2407-14-443-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/3dca80261674/1471-2407-14-443-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/c0145ecfc6f9/1471-2407-14-443-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb7/4071217/465ed521adb4/1471-2407-14-443-8.jpg

相似文献

1
MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells.微小RNA-26a通过直接靶向结肠癌细胞中的丙酮酸脱氢酶复合物E1α亚基来调节葡萄糖代谢。
BMC Cancer. 2014 Jun 16;14:443. doi: 10.1186/1471-2407-14-443.
2
Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.miR-27b 通过抑制 PDHX 基因表达来调控细胞代谢并促进乳腺癌的生长。
Mol Cancer. 2018 Jul 16;17(1):100. doi: 10.1186/s12943-018-0851-8.
3
miR-26a is Involved in Glycometabolism and Affects Boar Sperm Viability by Targeting .miR-26a 参与糖代谢,并通过靶向. 影响猪精子活力。
Cells. 2020 Jan 8;9(1):146. doi: 10.3390/cells9010146.
4
MiR-26a downregulates retinoblastoma in colorectal cancer.微小RNA-26a下调结直肠癌中的视网膜母细胞瘤。
Tumour Biol. 2017 Apr;39(4):1010428317695945. doi: 10.1177/1010428317695945.
5
microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.微小RNA-26a和-584通过抑制异质性核糖核蛋白A1与细胞周期蛋白依赖性激酶6信使核糖核酸的结合来抑制结直肠癌进展。
Biochem Biophys Res Commun. 2015 Nov 27;467(4):847-52. doi: 10.1016/j.bbrc.2015.10.055. Epub 2015 Oct 19.
6
MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.微小 RNA-135b 调节转移抑制因子 1 的表达,促进结直肠癌的迁移和侵袭。
Mol Cell Biochem. 2014 Mar;388(1-2):249-59. doi: 10.1007/s11010-013-1916-z. Epub 2013 Dec 17.
7
Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.受微小RNA负调控的乳酸脱氢酶A促进有氧糖酵解并在结直肠癌中升高。
Oncotarget. 2015 Aug 14;6(23):19456-68. doi: 10.18632/oncotarget.3318.
8
Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.微小RNA-26a的下调与骨肉瘤患者的转移潜能及不良预后相关。
Oncol Rep. 2014 Mar;31(3):1263-70. doi: 10.3892/or.2014.2989. Epub 2014 Jan 21.
9
Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.致癌长链非编码 RNA ZNF561-AS1 通过调节 miR-26a-3p/miR-128-5p-SRSF6 轴对结直肠癌细胞增殖和存活至关重要。
J Exp Clin Cancer Res. 2021 Feb 23;40(1):78. doi: 10.1186/s13046-021-01882-1.
10
miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.miR-26a 及其靶基因 CKS2 调节甲状腺乳头状癌细胞的生长和肿瘤发生。
PLoS One. 2013 Jul 5;8(7):e67591. doi: 10.1371/journal.pone.0067591. Print 2013.

引用本文的文献

1
The crosstalk between non-coding RNAs and oxidative stress in cancer progression.非编码RNA与氧化应激在癌症进展中的相互作用。
Genes Dis. 2024 Apr 10;12(3):101286. doi: 10.1016/j.gendis.2024.101286. eCollection 2025 May.
2
Linking microRNA to metabolic reprogramming and gut microbiota in the pathogenesis of colorectal cancer (Review).在结直肠癌发病机制中将微小RNA与代谢重编程和肠道微生物群相联系(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5487. Epub 2025 Jan 17.
3
Implication of microRNAs as messengers of exercise adaptation in junior female triathlonists.

本文引用的文献

1
Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.验证 NCM460 细胞模型作为靶向结肠腺癌代谢重编程抗肿瘤策略的对照:以曲古抑菌素 A 为例
Biochim Biophys Acta. 2014 Jun;1840(6):1634-9. doi: 10.1016/j.bbagen.2013.12.024. Epub 2013 Dec 22.
2
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.肿瘤相关成纤维细胞中的碳酸酐酶 IX 驱动前列腺癌细胞中的上皮-间充质转化。
Cell Cycle. 2013 Jun 1;12(11):1791-801. doi: 10.4161/cc.24902. Epub 2013 May 8.
3
微 RNA 作为青少年女性三项全能运动员适应运动的信使的意义。
Sci Rep. 2024 Oct 1;14(1):22858. doi: 10.1038/s41598-024-73670-8.
4
RREB1-mediated SUMOylation enhancement promotes chemoresistance partially by transcriptionally upregulating in colorectal cancer.RREB1介导的SUMO化增强通过转录上调部分促进结直肠癌的化疗耐药性。
Front Pharmacol. 2024 Jul 23;15:1381860. doi: 10.3389/fphar.2024.1381860. eCollection 2024.
5
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.长链非编码RNA MALAT-1:癌症进展、转移、免疫及治疗抗性中的多功能调节因子
Noncoding RNA Res. 2024 Feb 1;9(2):388-406. doi: 10.1016/j.ncrna.2024.01.015. eCollection 2024 Jun.
6
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.靶向瓦伯格效应:从分子机制到癌症传统与创新治疗策略的新视角
Acta Pharm Sin B. 2024 Mar;14(3):953-1008. doi: 10.1016/j.apsb.2023.12.003. Epub 2023 Dec 16.
7
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma.微小RNA作为肾细胞癌中糖原合成酶激酶-3β的潜在调节因子
Curr Issues Mol Biol. 2023 Sep 11;45(9):7432-7448. doi: 10.3390/cimb45090470.
8
Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.失调的微小RNA在T细胞恶性肿瘤中的诊断意义及其代谢作用。
Front Oncol. 2023 Aug 10;13:1230273. doi: 10.3389/fonc.2023.1230273. eCollection 2023.
9
Recent advances microRNAs and metabolic reprogramming in colorectal cancer research.结直肠癌研究中微小RNA与代谢重编程的最新进展。 (原英文文本表述有误,正确的应该是“Recent advances in microRNAs and metabolic reprogramming in colorectal cancer research.” )
Front Oncol. 2023 Jul 27;13:1165862. doi: 10.3389/fonc.2023.1165862. eCollection 2023.
10
The role of noncoding RNAs in metabolic reprogramming of cancer cells.非编码 RNA 在癌细胞代谢重编程中的作用。
Cell Mol Biol Lett. 2023 May 9;28(1):37. doi: 10.1186/s11658-023-00447-8.
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
微小 RNA-26a 通过靶向白细胞介素 6-Stat3 通路抑制人肝癌的肿瘤生长和转移。
Hepatology. 2013 Jul;58(1):158-70. doi: 10.1002/hep.26305. Epub 2013 Jun 5.
4
Roles of microRNA on cancer cell metabolism.miRNA 在肿瘤细胞代谢中的作用。
J Transl Med. 2012 Nov 20;10:228. doi: 10.1186/1479-5876-10-228.
5
MicroRNA and cancer.微小 RNA 与癌症。
Mol Oncol. 2012 Dec;6(6):590-610. doi: 10.1016/j.molonc.2012.09.006. Epub 2012 Oct 9.
6
Delivering the promise of miRNA cancer therapeutics.实现 miRNA 癌症疗法的承诺。
Drug Discov Today. 2013 Mar;18(5-6):282-9. doi: 10.1016/j.drudis.2012.10.002. Epub 2012 Oct 11.
7
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.微小RNA-26a通过靶向磷酸酶及张力蛋白同源物(PTEN)经由蛋白激酶B(AKT)信号通路增强肺癌细胞的转移潜能。
Biochim Biophys Acta. 2012 Nov;1822(11):1692-704. doi: 10.1016/j.bbadis.2012.07.019. Epub 2012 Aug 4.
8
Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.抑制 HIF-1α/PDK3 信号轴促使黑色素瘤向线粒体氧化代谢转化,并增强促氧化剂的治疗活性。
Cancer Res. 2012 Oct 1;72(19):5035-47. doi: 10.1158/0008-5472.CAN-12-0979. Epub 2012 Aug 3.
9
Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.通过乳酸穿梭实现的代谢互惠重编程协调影响肿瘤-基质相互作用。
Cancer Res. 2012 Oct 1;72(19):5130-40. doi: 10.1158/0008-5472.CAN-12-1949. Epub 2012 Jul 31.
10
Pyruvate dehydrogenase deficiency caused by a new mutation of PDHX gene in two Moroccan patients.两名摩洛哥患者中由PDHX基因新突变引起的丙酮酸脱氢酶缺乏症。
Eur J Med Genet. 2012 Oct;55(10):535-40. doi: 10.1016/j.ejmg.2012.06.006. Epub 2012 Jul 20.